Eraflu Dosage/Direction for Use

Posology: Adults, and adolescents 13 years and over: Treatment: The recommended oral dose is 75 mg oseltamivir twice daily for 5 days for adolescents (13 to 17 years of age) and adults. (See Table 2.)

Click on icon to see table/diagram/image

Treatment should be initiated as soon as possible within the first two days of onset of symptoms of influenza.
Post-exposure prevention: The recommended dose for prevention of influenza following close contact with an infected individual is 75 mg oseltamivir once daily for 10 days for adolescents (13 to 17 years of age) and adults. (See Table 3.)

Click on icon to see table/diagram/image

Therapy should begin as soon as possible within two days of exposure to an infected individual.
Prevention during an influenza epidemic in the community: The recommended dose for prevention of influenza during a community outbreak is 75 mg oseltamivir once daily for up to 6 weeks.
Special populations: Hepatic impairment: No dose adjustment is required either for treatment or for prevention in patients with hepatic dysfunction. No studies have been carried out in paediatric patients with hepatic disorder.
Renal impairment: Treatment of influenza: Dose adjustment is recommended for adults and adolescents (13 to 17 years of age) with moderate or severe renal impairment. Recommended doses are detailed in Table 4. (See Table 4.)

Click on icon to see table/diagram/image

Prevention of influenza: Dose adjustment is recommended for adults and adolescents (13-17 years of age) with moderate or severe renal patients as detailed in Table 5. (See Table 5.)

Click on icon to see table/diagram/image

Elderly: No dose adjustment is required, unless there is evidence of moderate or severe renal impairment.
Immunocompromised patients: Longer duration of seasonal prophylaxis up to 12 weeks has been evaluated in immunocompromised patients.
Method of administration: Oral use.